AKT1 and neoplasm: Exosomal lncRNA regulator of Akt signaling Associated with HCC and RCC (lncARSR) released by resistant renal tumor cells mediates sunitinib resistance in tumor and endothelial cells, both targets of this kind of therapy, by competitively binding to miR-34 and miR-449 [97].